[{"indications": "Indications\u00a0diabetes mellitus; diabetic ketoacidosis\r\n(section 6.1.3)", "name": "INSULIN Human sequence", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.1 Drugs used in diabetes", "6.1.1 Insulins", "6.1.1.1 Short-acting insulins", "INSULIN", "Human sequence"], "cautions": "Cautions\u00a0section 6.1.1; interactions: Appendix 1 (antidiabetics)", "side-effects": "Side-effects\u00a0see notes above; transient\r\noedema; local reactions and fat hypertrophy at injection site; rarely hypersensitivity reactions including urticaria, rash;\r\noverdose causes hypoglycaemia", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4090.htm", "doses": ["By subcutaneous, intramuscular or intravenous injection or intravenous infusion, according to requirements", "Name[Humulin S\u00ae (Lilly) ] Injection, soluble insulin (human, prb) 100\u00a0units/mL. Net price 10-mL vial = \u00a315.68; 5 \u00d7 3-mL\r\ncartridge (for most Autopen\u00ae Classic or HumaPen\u00ae) = \u00a319.08Counselling\u00a0Show container to patient and confirm\r\nthat patient is expecting the version dispensed"], "pregnancy": "Pregnancy\u00a0section 6.1.1"}]